subjects with local allergic rhinitis can be identified by basophil activation test

1
ORAL PRESENTATION Open Access Subjects with local allergic rhinitis can be identified by basophil activation test Paloma Campo 1* , Carmen Rondon 1 , Enrique Gomez 2 , Natalia Blanca-Lopez 3 , M Jose Torres 1 , Esther Barrionuevo 1 , Rocio Herrera 1 , Luisa Galindo 1 , Cristobalina Mayorga 2 , Miguel Blancal 1 From 9th Symposium of Experimental Rhinology and Immunology of the Nose (SERIN 2013) Leuven, Belgium. 21-23 March 2013 Background Local allergic rhinitis (LAR) is characterized by negative skin testing and serum specific IgE. Diagnosis is based on nasal provocation test (NPT), very sensitive but time-consuming, and/or presence of local synthesis of specific IgE (sIgE) which shows low sensitivity (22%). The aim of the study was to evaluate the presence of specific D. pteronyssinus (DP) activation of basophils by basophil activation test (BAT) in subjects with con- firmed LAR. Methods BAT was performed in 43 subjects: 16 with confirmed LAR (positive NPT with DP, negative skin testing and sIgE to DP), 13 with allergic rhinitis (AR)(positive NPT with DP, positive skin testing and sIgE to DP) and 14 healthy controls (negative NPT, negative skin testing and sIgE to DP). To demonstrate a specific IgE mechanism of basophil activation, BAT with wortmannin pre-treatment was per- formed in four LAR patients. Results BAT with DP was positive in 85% of AR patients and 50% of LAR subjects. BAT showed a substantial correlation with NPT in AR subjects (kappa index: 0.78, p=0.0001). The positive responses of the 4 LAR samples that under- went BAT with wortmannin became negative when this substance was added to the assay. Conclusions BAT was able to detect 50% of LAR subjects to DP, being more sensitive than detection of nasal specific IgE. Responses were IgE-specific demonstrated by BAT- wortmannin assay. Further studies are needed to test this assay with other allergens. Author details 1 Carlos Haya Hospital, Allergy Service, Malaga, Spain. 2 Carlos Haya Hospital, Allergy Research Laboratory, Malaga, Spain. 3 Infanta Leonor Hospital, Allergy Service, Madrid, Spain. Published: 16 July 2013 doi:10.1186/2045-7022-3-S2-O18 Cite this article as: Campo et al.: Subjects with local allergic rhinitis can be identified by basophil activation test. Clinical and Translational Allergy 2013 3(Suppl 2):O18. Submit your next manuscript to BioMed Central and take full advantage of: Convenient online submission Thorough peer review No space constraints or color figure charges Immediate publication on acceptance Inclusion in PubMed, CAS, Scopus and Google Scholar Research which is freely available for redistribution Submit your manuscript at www.biomedcentral.com/submit 1 Carlos Haya Hospital, Allergy Service, Malaga, Spain Full list of author information is available at the end of the article Campo et al. Clinical and Translational Allergy 2013, 3(Suppl 2):O18 http://www.ctajournal.com/content/3/S2/O18 © 2013 Campo et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Upload: enrique-gomez

Post on 11-Dec-2016

212 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Subjects with local allergic rhinitis can be identified by basophil activation test

ORAL PRESENTATION Open Access

Subjects with local allergic rhinitis can beidentified by basophil activation testPaloma Campo1*, Carmen Rondon1, Enrique Gomez2, Natalia Blanca-Lopez3, M Jose Torres1, Esther Barrionuevo1,Rocio Herrera1, Luisa Galindo1, Cristobalina Mayorga2, Miguel Blancal1

From 9th Symposium of Experimental Rhinology and Immunology of the Nose (SERIN 2013)Leuven, Belgium. 21-23 March 2013

BackgroundLocal allergic rhinitis (LAR) is characterized by negativeskin testing and serum specific IgE. Diagnosis is basedon nasal provocation test (NPT), very sensitive buttime-consuming, and/or presence of local synthesis ofspecific IgE (sIgE) which shows low sensitivity (22%).The aim of the study was to evaluate the presence ofspecific D. pteronyssinus (DP) activation of basophils bybasophil activation test (BAT) in subjects with con-firmed LAR.

MethodsBAT was performed in 43 subjects: 16 with confirmedLAR (positive NPT with DP, negative skin testing and sIgEto DP), 13 with allergic rhinitis (AR)(positive NPT withDP, positive skin testing and sIgE to DP) and 14 healthycontrols (negative NPT, negative skin testing and sIgE toDP). To demonstrate a specific IgE mechanism of basophilactivation, BAT with wortmannin pre-treatment was per-formed in four LAR patients.

ResultsBAT with DP was positive in 85% of AR patients and 50%of LAR subjects. BAT showed a substantial correlationwith NPT in AR subjects (kappa index: 0.78, p=0.0001).The positive responses of the 4 LAR samples that under-went BAT with wortmannin became negative when thissubstance was added to the assay.

ConclusionsBAT was able to detect 50% of LAR subjects to DP,being more sensitive than detection of nasal specific IgE.Responses were IgE-specific demonstrated by BAT-

wortmannin assay. Further studies are needed to testthis assay with other allergens.

Author details1Carlos Haya Hospital, Allergy Service, Malaga, Spain. 2Carlos Haya Hospital,Allergy Research Laboratory, Malaga, Spain. 3Infanta Leonor Hospital, AllergyService, Madrid, Spain.

Published: 16 July 2013

doi:10.1186/2045-7022-3-S2-O18Cite this article as: Campo et al.: Subjects with local allergic rhinitis canbe identified by basophil activation test. Clinical and Translational Allergy2013 3(Suppl 2):O18.

Submit your next manuscript to BioMed Centraland take full advantage of:

• Convenient online submission

• Thorough peer review

• No space constraints or color figure charges

• Immediate publication on acceptance

• Inclusion in PubMed, CAS, Scopus and Google Scholar

• Research which is freely available for redistribution

Submit your manuscript at www.biomedcentral.com/submit1Carlos Haya Hospital, Allergy Service, Malaga, Spain

Full list of author information is available at the end of the article

Campo et al. Clinical and Translational Allergy 2013, 3(Suppl 2):O18http://www.ctajournal.com/content/3/S2/O18

© 2013 Campo et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative CommonsAttribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction inany medium, provided the original work is properly cited.